Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
RELATED RESEARCH RESOURCES AND LINKS
ListGraphMap
Displaying 1 - 10 of 18 Projects
Project # Contact PI Funding Organization Fiscal Year
Neurochemical basis of ethnic diversity in Alzheimer's Disease diagnostics
AARF-21-850325 Thomas Kwaku Karikari Alzheimer's Association 2021
Etiology and progression of Suspected non-Alzheimer’s pathophysiology
AARF-19-615258 Wisse, Laura Alzheimer's Association 2019
The expanded Alzheimer’s Association quality control (QC) program for CSF and plasma biomarkers
QC CSF 3-19-624883 Blennow, Kaj Alzheimer's Association 2019
Búsqueada de bio-marcadores sinápticos en la enfermedad de Alzheimer
EUJPND-Spain-Clinical-BELBIN-1302 BELBIN, OLIVIA Clinical 2016
ASSESSMENT AND CHARACTERIZATION OF BIOMARCATORS OF THE PRECLINIC STADIUM OF ALZHEIMER'S DISEASE
EUJPND-SpainISC-BELBIN-1313 BELBIN, OLIVIA INSTITUTO DE SALUD CARLOS III. ACCIÓN ESTRATEGICA EN SALUD 2016
ALZHEIMER'S DISEASE AND DOWN SYNDROME. MULTIMODAL STUDIES OF CLEAR LIQUID, MAGNETIC RESONANCE AND PET OF AMYLOID.
EUJPND-SpainISC-BLESA GONZALEZ-1316 BLESA GONZALEZ, RAFAEL INSTITUTO DE SALUD CARLOS III. ACCIÓN ESTRATEGICA EN SALUD 2016
STUDY OF BIOMARKERS IN THE CONTINUOUS PATHOLOGICAL EXISTING BETWEEN LATERAL AMIOTROPHIC SCLEROSIS (ELA) AND LOBULAR DEVELOPMENT FRONTOTEMPORAL (DLFT) - I
EUJPND-SpainISC-GARCIA REDONDO-1337 GARCIA REDONDO, ALBERTO INSTITUTO DE SALUD CARLOS III. ACCIÓN ESTRATEGICA EN SALUD 2016
CLINICAL PHENOTYPES AND NEW PHYSIOPATHOLOGICAL, DIAGNOSTIC AND PROGNOSTIC BIOMARCATORS IN ALZHEIMER'S DISEASE OF PRECIOUS START AND BEHAVIORAL BEHAVIOR OF FRONTOTEMPORA DEMENTIA
EUJPND-SpainISC-LLADO PLARRUMANI-1350 LLADO PLARRUMANI, ALBERT INSTITUTO DE SALUD CARLOS III. ACCIÓN ESTRATEGICA EN SALUD 2016
SYNAPTIC MARKERS IN ALZHEIMER'S DISEASE
EUJPND-SpainISC-LLEO BISA-1351 LLEO BISA, ALBERTO INSTITUTO DE SALUD CARLOS III. ACCIÓN ESTRATEGICA EN SALUD 2016
STUDY OF BIOMARKERS IN THE CONTINUOUS PATHOLOGICAL EXISTING BETWEEN LATERAL AMIOTROPHIC SCLEROSIS (ELA) AND FRONTOTEMPORAL LOBULAR DEGENERATION (DLFT) -II
EUJPND-SpainISC-OSTA PINZOLAS-1360 OSTA PINZOLAS, ROSARIO INSTITUTO DE SALUD CARLOS III. ACCIÓN ESTRATEGICA EN SALUD 2016